Cargando…
Mitomycin C treatment induces resistance and enhanced migration via phosphorylated Akt in aggressive lung cancer cells
Since 1984, mitomycin C (MMC) has been applied in the treatment of non-small-cell lung cancer (NSCLC). MMC-based chemotherapeutic regimens are still under consideration owing to the efficacy and low cost as compared with other second-line regimens in patients with advanced NSCLC. Hence, it is import...
Autores principales: | Shen, Cheng-Ying, Chen, Li-Han, Lin, Yu-Fen, Lai, Liang-Chuan, Chuang, Eric Y., Tsai, Mong-Hsun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346766/ https://www.ncbi.nlm.nih.gov/pubmed/27833080 http://dx.doi.org/10.18632/oncotarget.13237 |
Ejemplares similares
-
Semaphorin 6A Attenuates the Migration Capability of Lung Cancer Cells via the NRF2/HMOX1 Axis
por: Chen, Li-Han, et al.
Publicado: (2019) -
Semaphorin 5A suppresses the proliferation and migration of lung adenocarcinoma cells
por: Ko, Pin-Hao, et al.
Publicado: (2019) -
MicroRNA-449a Enhances Radiosensitivity in CL1-0 Lung Adenocarcinoma Cells
por: Liu, Yi-Jyun, et al.
Publicado: (2013) -
MicroRNA-107 enhances radiosensitivity by suppressing granulin in PC-3 prostate cancer cells
por: Lo, Hua-Cheng, et al.
Publicado: (2020) -
ADAM9 Up-Regulates N-Cadherin via miR-218 Suppression in Lung Adenocarcinoma Cells
por: Sher, Yuh-Pyng, et al.
Publicado: (2014)